Medulloblastoma: Histological Evaluation and Prognosis. A Clinical, Immunohistochemical and Electron Microscopic Study

Overview

Journal Childs Nerv Syst

Specialty Pediatrics

Date 1987 Jan 1

PMID 3304626

Citations 2

Authors

J Szymas

W Biczysko

P Gabryel

S Morkowski

Affiliations

Soon will be listed here.

Abstract

Eighty-four cases of medulloblastoma were examined immunohistochemically and 12 by electron microscopy to assess differentiation in these tumors. Based upon the largest series of medulloblastoma studied to date, we demonstrated glial fibrillary acidic protein (GFAP) positivity, in 25% (21/84) of these tumors showing glial differentiation. GFAP-positive cells were seen more frequently in the desmoplastic variant of medulloblastoma (7/10). Under electron microscopy, the major part of the 12 tumors studied appeared primitive and undifferentiated. In 7 cases, groups of cells were found with primitive neuronal and/or glial features. GFAP positivity was confirmed at light microscopy level in all cases where cells showed glial differentiation in the form of glial-like filaments in cytoplasma. However, a follow-up questionnaire study of those patients who had received only surgical treatment revealed no difference in mean survival time between GFAP-positive and GFAP-negative medulloblastoma.

Citing Articles

Human fetal spinal cord xenografted to the eye of athymic nude rats: survival, ultrastructural differentiation, glial responses and vascular interactions.

Inoue H, Henschen A, Olson L J Electron Microsc (Tokyo). 1994; 43(1):1-9.

PMID: 8021560 DOI: 10.1007/BF02348220.

Medulloblastoma in children and in adults: a comparative study.

Maleci A, Cervoni L, Delfini R Acta Neurochir (Wien). 1992; 119(1-4):62-7.

PMID: 1481754 DOI: 10.1007/BF01541783.

References

Moss T . Evidence for differentiation in medulloblastomas appearing primitive on light microscopy: an ultrastructural study. Histopathology. 1983; 7(6):919-30. DOI: 10.1111/j.1365-2559.1983.tb02306.x. View

Kopelson G, Linggood R, Kleinman G . Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management. Cancer. 1983; 51(2):312-9. DOI: 10.1002/1097-0142(19830115)51:2<312::aid-cncr2820510225>3.0.co;2-y. View

Eng L, Rubinstein L . Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors. J Histochem Cytochem. 1978; 26(7):513-22. DOI: 10.1177/26.7.357640. View

Tremblay G, Lee V, Trojanowski J . Expression of vimentin, glial filament, and neurofilament proteins in primitive childhood brain tumors. A comparative immunoblot and immunoperoxidase study. Acta Neuropathol. 1985; 68(3):239-44. DOI: 10.1007/BF00690201. View

van der Meulen J, Houthoff H, EBELS E . Glial fibrillary acidic protein in human gliomas. Neuropathol Appl Neurobiol. 1978; 4(3):177-90. DOI: 10.1111/j.1365-2990.1978.tb00534.x. View

Szymas J . [Glial fibrillary acidic protein. A valuable tool for neuropathologic diagnosis. An introduction]. Zentralbl Allg Pathol. 1986; 131(1):3-19. View

BLOOM H, Wallace E, Henk J . The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases. Am J Roentgenol Radium Ther Nucl Med. 1969; 105(1):43-62. DOI: 10.2214/ajr.105.1.43. View

MATAKAS F, Cervos-Navarro J, Gullotta F . The ultrastructure of medulloblastomas. Acta Neuropathol. 1970; 16(4):271-84. DOI: 10.1007/BF00686892. View

Deck J, Eng L, Bigbee J, WOODCOCK S . The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors. Acta Neuropathol. 1978; 42(3):183-90. DOI: 10.1007/BF00690355. View

10.

Ward H . Central nervous system tumors of childhood treated with CCNU, vincristine, and radiation. Med Pediatr Oncol. 1978; 4(4):315-20. DOI: 10.1002/mpo.2950040407. View

11.

Roy S . An ultrastructural study of medulloblastoma. Neurol India. 1977; 25(4):226-9. View

12.

Chatty E, EARLE K . Medulloblastoma. A report of 201 cases with emphasis on the relationship of histologic variants to survival. Cancer. 1971; 28(4):977-83. DOI: 10.1002/1097-0142(1971)28:4<977::aid-cncr2820280422>3.0.co;2-7. View

13.

Lyser K . Human nervous system tumors. Observations by high voltages electron microscopy. Acta Neuropathol. 1975; 32(4):313-24. DOI: 10.1007/BF00696793. View

14.

Mooney C, Souhami R, Pritchard J . Recurrent medulloblastoma. Lack of response to high-dose methotrexate. Cancer Chemother Pharmacol. 1983; 10(2):135-6. DOI: 10.1007/BF00446227. View

15.

Soejima T . Fine structure of medulloblastoma. Gan. 1970; 61(1):17-26. View

16.

van Eys J, Chen T, Moore T, CHEEK W, Sexauer C, Starling K . Adjuvant chemotherapy for medulloblastoma and ependymoma using iv vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: a Southwest Oncology Group Study. Cancer Treat Rep. 1981; 65(7-8):681-4. View

17.

PALMER J, Kasselberg A, NETSKY M . Differentiation of Medulloblastoma. Studies including immunohistochemical localization of glial fibrillary acidic protein. J Neurosurg. 1981; 55(2):161-9. DOI: 10.3171/jns.1981.55.2.0161. View

18.

Crafts D, Levin V, Edwards M, Pischer T, Wilson C . Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine. J Neurosurg. 1978; 49(4):589-92. DOI: 10.3171/jns.1978.49.4.0589. View

19.

Coffin C, Mukai K, Dehner L . Glial differentiation in medulloblastomas. Histogenetic insight, glial reaction, or invasion of brain?. Am J Surg Pathol. 1983; 7(6):555-65. DOI: 10.1097/00000478-198309000-00006. View

20.

Cangir A, Ragab A, Steuber P, Land V, Berry D, Krischer J . Combination chemotherapy with vincristine (NSC-67574), procarbazine (NSC-77213), prednisone (NSC-10023) with or without nitrogen mustard (NSC-762)(MOPP vs OPP) in children with recurrent brain tumors. Med Pediatr Oncol. 1984; 12(1):1-3. DOI: 10.1002/mpo.2950120103. View